Monday, April 9, 2012
Companies are concerned that
expanded use of coverage with evidence development by the Centers for
Medicare & Medicaid Services could restrict access to new drugs, but
not all doctors and policy specialists agree.
Once drugs or devices are
approved by FDA, CMS is required by law to cover those that are "reasonable
and necessary," although the term itself does not have a precise legal